5 rezultātiem
BACKGROUND
Methotrexate (MTX) is potential change in immunosuppression after lung transplantation that may help to slow down the decline in lung function in bronchiolitis obliterans syndrome (BOS).
METHODS
We sought to analyze the safety and efficacy of MTX in patients with BOS, by retrospective
We report an immunodeficient patient with a rare gastrointestinal manifestation. A 26-year-old male with common variable immunodeficiency (CVID) and bronchiolitis obliterans, who was on intravenous gamma-globulin and prednisone, presented diffuse abdominal pain, nausea, vomiting and constipation of
Efalizumab is a recombinant humanised IgG1 kappa isotype monoclonal antibody against the CD11a molecule. Efalizumab is approved for the treatment of moderate-to-severe psoriasis and is currently administered as a weekly subcutaneous injection. Throughout October 2005, 19,000 patients were treated
BACKGROUND
Standard immunosuppression after lung transplantation includes calcineurin inhibitors, azathioprine, and steroids. Calcineurin inhibitor administration is associated with an increased renal impairment. Sirolimus shows no renal toxicity and could be used in selected patients.
METHODS
We
BACKGROUND
We observed an unexpectedly high incidence of postoperative gastroparesis among lung and heart-lung transplant recipients.
OBJECTIVE
To identify the incidence of GI complications and to describe the clinical profiles of patients who developed symptomatic gastroparesis after lung